Ken Griffin Opko Health, Inc. Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Opko Health, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 228,200 shares of OPK stock, worth $317,198. This represents 0.0% of its overall portfolio holdings.
Number of Shares
228,200
Previous 370,400
38.39%
Holding current value
$317,198
Previous $614,000
50.98%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding OPK
# of Institutions
240Shares Held
207MCall Options Held
1.49MPut Options Held
332K-
Rubric Capital Management LP New York, NY47.8MShares$66.4 Million1.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA38.2MShares$53.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY29.2MShares$40.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA10.4MShares$14.5 Million0.0% of portfolio
-
State Street Corp Boston, MA8.58MShares$11.9 Million0.0% of portfolio
About OPKO HEALTH, INC.
- Ticker OPK
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 771,960,000
- Market Cap $1.07B
- Description
- OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...